Retinal microangiopathy in a mouse model of inducible mural cell loss.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Pathology

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2014.06.011PMID 25092275PMCID PMC4715212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels.

  2012cited by this paper
• Diabetic retinopathy.

  2012cited by this paper
• Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy

  2012cited by this paper
• Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals

  2012cited by this paper
• Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.

  2012cited by this paper
• Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

  2012cited by this paper
• Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.

  2011cited by this paper
• Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy

  2011cited by this paper
• Characterization of a mouse model of hyperglycemia and retinal neovascularization.

  2010cited by this paper
• Pericytes regulate the blood–brain barrier

  2010cited by this paper
• Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization.

  2010cited by this paper
• Proliferative retinopathies: angiogenesis that blinds.

  2010cited by this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cited by this paper
• Surgical management of the late complications of proliferative diabetic retinopathy

  2010cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)

  2010cited by this paper
• Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy

  2009cited by this paper
• Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation.

  2009cited by this paper
• The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

  2009cited by this paper
• Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression

  2008cited by this paper
• G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension

  2008cited by this paper
• Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

  2008cited by this paper
• Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high‐risk proliferative diabetic retinopathy (IBeHi study)

  2008cited by this paper
• Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy

  2007cited by this paper
• Arteriolar Involvement in the Microvascular Lesions of Diabetic Retinopathy: Implications for Pathogenesis

  2007cited by this paper
• Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis

  2006cited by this paper
• Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.

  2006cited by this paper
• Diabetic Retinopathy

  2006cited by this paper
• Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

  2006cited by this paper
• Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3

  2006cited by this paper
• The Ins2Akita mouse as a model of early retinal complications in diabetes.

  2005cited by this paper
• A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration

  2005cited by this paper
• Pericytes and the Pathogenesis of Diabetic Retinopathy

  2005cited by this paper
• Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabetic retinopathy.

  2005cited by this paper
• Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.

  2005cited by this paper
• NG2‐expressing cells in the nervous system: role of the proteoglycan in migration and glial–neuron interaction

  2005cited by this paper
• Cell Depletion Due to Diphtheria Toxin Fragment A after Cre-Mediated Recombination

  2004cited by this paper
• The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States.

  2004cited by this paper
• A central role for inflammation in the pathogenesis of diabetic retinopathy

  2004cited by this paper
• Death of retinal neurons in streptozotocin-induced diabetic mice.

  2004cited by this paper
• Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.

  2004cited by this paper
• Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.

  2003cited by this paper
• Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy

  2002cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

  2000cited by this paper
• Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.

  1999cited by this paper
• Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

  1999cited by this paper
• Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

  1997cited by this paper
• Major DNA Fragmentation Is a Late Event in Apoptosis

  1997cited by this paper
• Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

  1997cited by this paper
• A mouse model of diabetic retinopathy.

  1996cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models.

  1993cited by this paper
• Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy.

  1992cited by this paper
• Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

  1989cited by this paper
• Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio.

  1989cited by this paper
• An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.

  1989cited by this paper
• Pathogenesis of Diabetic Retinopathy

  1989cited by this paper
• Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells

  1987cited by this paper
• Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations

  1985cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

  1984cited by this paper
• Proliferative diabetic retinopathy

  1973cited by this paper
• Proliferative diabetic retinopathy. Site and size of initial lesions.

  1970cited by this paper
• Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes.

  1968cited by this paper
• The mural cell in perspective.

  1967cited by this paper
• [Studies on diabetic retinopathy].

  1966cited by this paper
• Aneurysms on new-formed pre-papillary and pre-retinal vessels in proliferative diabetic retinopathy.

  1966cited by this paper
• DIABETIC RETINOPATHY.

  1964cited by this paper
• Retinal vascular patterns. VI. Mural cells of the retinal capillaries.

  1963cited by this paper
• Retinal vascular patterns. IV. Diabetic retinopathy.

  1961cited by this paper
• Studies of Retinal Vascular Patterns: Part I. Normal Architecture

  1960cited by this paper
• Studies of retinal vascular patterns. I. Normal architecture.

  1960cited by this paper

• Targeting Myostatin as an Adjunct Treatment for the Preservation of Cardiometabolic and Skeletal Muscle Function in Type 1 Diabetes

  2025cites this paper
• Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review

  2025cites this paper
• Elucidating programmed cell death in diabetic retinal microangionopathy and neurodegeneration: unraveling molecular mechanisms and therapeutic actions of natural products

  2025cites this paper
• Ets2 Exacerbates Diabetic Retinopathy by Aggravating the Proliferation of Endothelial Cells and Inflammatory Response

  2024cites this paper
• Correlation study of renal function indices with diabetic peripheral neuropathy and diabetic retinopathy in T2DM patients with normal renal function

  2023cites this paper
• Ganglion cell complex and retinal nerve fiber layer thickness in gestational diabetes mellitus

  2022cites this paper
• Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death

  2022cites this paper
• VEGFR1 signaling in retinal angiogenesis and microinflammation

  2021cites this paper
• Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease

  2020cites this paper
• Characterization of Retinal Microvascular Complications and the Effects of Endoplasmic Reticulum Stress in Mouse Models of Diabetic Atherosclerosis

  2020cites this paper
• Pericytes in Type 2 Diabetes.

  2019cites this paper
• Pericytes in the Lung.

  2019cites this paper
• Microvascular bioengineering: a focus on pericytes

  2019cites this paper
• Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

  2018cites this paper
• Targeting pericytes for therapeutic approaches to neurological disorders

  2018cites this paper
• NLRP1 deficiency attenuates diabetic retinopathy (DR) in mice through suppressing inflammation response.

  2018cites this paper
• Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction

  2018cites this paper
• Endothelial Wnt-Pathway Activation Protects the Blood-Retinal-Barrier during Neurodegeneration-Induced Vasoregression

  2018influential citation
• Long-term consequences of developmental vascular defects on retinal vessel homeostasis and function in a mouse model of Norrie disease

  2017cites this paper
• Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL

  2017cites this paper
• Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond

  2017cites this paper
• CLINICAL FINDINGS OF EYES WITH MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION REFRACTORY TO RANIBIZUMAB

  2017cites this paper
• Diabetic Retinopathy: Battling the Global Epidemic

  2016cites this paper
• Streptozotocin-induced diabetes, and the optic nerve blood barrier.

  2016cites this paper
• Ablation of Pericyte‐Like Cells in Lungs by Oropharyngeal Aspiration of Diphtheria Toxin

  2016cites this paper
• Disorders of Vascular Permeability.

  2016cites this paper
• Diabetic retinopathy: Battling the global epidemic

  2016cites this paper
• Streptozotocin-induced diabetes, and the optic nerve blood barrier.

  2016cites this paper
• Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway.

  2015cites this paper
• Assessment of Macular Peripapillary Nerve Fiber Layer and Choroidal Thickness Changes in Pregnant Women with Gestational Diabetes Mellitus, Healthy Pregnant Women, and Healthy Non-Pregnant Women

  2015cites this paper
• Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy

  2015cites this paper